Clinical Trial Update: Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial studied rivaroxaban plus aspirin to manage recurrent venous thromboembolism, including venous thromboses and pulmonary embolism…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Venous Thromboembolism, Anticoagulant-induced Bleeding | Phase 2, Phase 3 | Status: COMPLETED